|
DE19602962A1
(de)
*
|
1995-12-20 |
1997-07-31 |
Nycomed Arzneimittel Gmbh |
Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
EP1422230B1
(en)
*
|
2002-11-25 |
2007-12-26 |
Chi Mei Foundation Medical Center |
Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions
|
|
KR100704085B1
(ko)
*
|
2002-12-02 |
2007-04-05 |
치 메이 파운데이션 메디칼 센터 |
신규한 부프레노핀 에스테르 유도체, 그의 제조 방법 및지속성 진통제 약학 조성물
|
|
US20050053659A1
(en)
|
2003-09-10 |
2005-03-10 |
Pace Gary W. |
Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
|
|
WO2008036858A2
(en)
|
2006-09-20 |
2008-03-27 |
The Board Of Regents Of The University Of Texas System |
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
|
|
AU2009206390B2
(en)
|
2008-01-22 |
2014-10-30 |
The Board Of Regents Of The University Of Texas System |
Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
|
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
|
AU2010266209B2
(en)
*
|
2009-07-02 |
2013-09-26 |
Kempharm, Inc. |
Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
|
|
US10849981B2
(en)
|
2009-07-02 |
2020-12-01 |
KemPham, Inc. |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
|
|
UA102916C2
(uk)
|
2009-07-02 |
2013-08-27 |
Кемфарм, Інк. |
Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
|
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
|
EP2353598A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for use in the prevention and/or treatment of postoperative pain
|
|
CA2794171C
(en)
|
2010-03-24 |
2018-07-03 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
|
EP2524694A1
(en)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
|
CA2933511A1
(en)
|
2013-12-17 |
2015-06-25 |
Laboratorios Del Dr. Esteve, S.A. |
Serotonin-norepinephrine reuptake inhibitors (snris) and sigma receptor ligands combinations
|
|
AU2015353502B2
(en)
|
2014-11-25 |
2018-09-27 |
Kempharm, Inc. |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
|
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12186296B1
(en)
|
2016-07-22 |
2025-01-07 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12478604B1
(en)
|
2016-07-22 |
2025-11-25 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US20180263936A1
(en)
|
2017-03-17 |
2018-09-20 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
WO2020012248A1
(en)
|
2018-07-13 |
2020-01-16 |
Alkermes Pharma Ireland Limited |
Novel naphthylenyl compounds for long-acting injectable compositions and related methods
|
|
US10807995B2
(en)
|
2018-07-13 |
2020-10-20 |
Alkermes Pharma Ireland Limited |
Thienothiophene compounds for long-acting injectable compositions and related methods
|
|
WO2020094634A1
(en)
|
2018-11-05 |
2020-05-14 |
Alkermes Pharma Ireland Limited |
Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods
|
|
US11400052B2
(en)
|
2018-11-19 |
2022-08-02 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|
|
CN119868330A
(zh)
|
2019-03-01 |
2025-04-25 |
弗拉梅尔爱尔兰有限公司 |
在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
|
|
TW202139986A
(zh)
|
2020-02-21 |
2021-11-01 |
愛爾蘭商爵士製藥愛爾蘭有限責任公司 |
治療原發性嗜睡症之方法
|
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|
|
CN118871420A
(zh)
*
|
2022-03-03 |
2024-10-29 |
暨南大学 |
可待因、其衍生物及中间体的制备方法
|